Pharmena (PHR)

Warsaw

Currency in PLN

3.36

-0.03(-0.88%)

Closed·24/04

Fair Value

Unlock Value

Day's Range

3.36

3.43

52 wk Range

2.50

4.45

PHR Income Statement

Featured here, the Income Statement (earnings report) for Pharmena, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Period Ending:

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

15.21

0.3

0.27

1.58

Total Revenues Growth

aa.aa

+53.16%

-98.03%

-10.37%

+488.43%

Cost Of Revenues

aa.aa

6.79

0.21

0.3

0.07

0.26

Gross Profit

aa.aa

8.43

0.09

-0

0.2

1.31

Gross Profit Growth

aa.aa

+32.08%

-98.92%

-101.1%

+19,900%

+563.13%

Gross Profit Margin %

aa.aa

55.39%

30.43%

-0.33%

73.88%

83.26%

Other Operating Expenses, Total

aa.aa

12.48

4.15

-32.81

3.6

4.59

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-0.27%	-66.73%	-890.22%	+110.98%	+27.55%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	12.02	3.84	3.96	3.58	4.59
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	0.47	0.31	-36.77	0.03	-0

Operating Income

aa.aa

-4.05

-4.06

32.81

-3.4

-3.28

Operating Income Growth

aa.aa

+33.92%

-0.17%

+907.9%

-110.37%

+3.61%

EBIT Margin %

aa.aa

-26.65%

-1,358.19%

10,972.91%

-1,269.78%

-207.99%

Net Interest Expenses

aa.aa

-0.27

-0.66

0.06

0.84

0.53

Net Interest Expenses Growth

aa.aa

-29.9%

-147.55%

+108.99%

+1,327.12%

-36.58%

Interest Expense, Total

aa.aa

-0.27

-0.66

-0.37

-0.04

-0.02

Interest And Investment Income

aa.aa

0.43

0.88

0.55

Other Non Operating Expenses, Total

aa.aa

-0.21

-0.25

-0.07

-0

-0.01

EBT, Excl. Unusual Items

aa.aa

-4.53

-4.97

32.8

-2.56

-2.75

Gain (Loss) On Sale Of Assets

aa.aa

0.04

0.01

0.02

Other Unusual Items, Total

aa.aa

0.03

0.08

0.01

EBT, Incl. Unusual Items

aa.aa

-4.46

-4.95

32.93

-2.56

-2.74

EBT, Incl. Unusual Items Growth

aa.aa

+28.94%

-11.15%

+764.61%

-107.77%

-7.31%

EBT, Incl. Unusual Items Margin

aa.aa

-29.3%

-1,656.86%

11,011.71%

-954.1%

-174%

Income Tax Expense

aa.aa

0.18

0.2

5.91

-1.3

0.03

Net Income to Company

aa.aa

-4.64

-1.62

28.95

-1.26

-2.77

Minority Interest

aa.aa

0.05

-0.01

Net Income

aa.aa

-4.59

-1.57

28.94

-1.26

-2.77

Net Income Growth

aa.aa

+33.36%

+65.81%

+1,943.38%

-104.36%

-119.41%

Net Income Margin %

aa.aa

-30.18%

-525.08%

9,679.26%

-470.9%

-175.59%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

-4.59

-5.11

27.01

-1.26

-2.77

Basic EPS - Continuing Operations

aa.aa

-0.41

-0.46

2.43

-0.11

-0.25

Basic EPS - Continuing Operations Growth

aa.aa

+34.11%

-11.05%

+628.36%

-104.67%

-119.41%

Diluted EPS - Continuing Operations

aa.aa

-0.41

-0.46

2.43

-0.11

-0.25

Diluted EPS - Continuing Operations Growth

aa.aa

+34.39%

-11.29%

+627.19%

-104.67%

-120.64%

Basic Weighted Average Shares Outstanding

aa.aa

11.11

11.14

Diluted Weighted Average Shares Outstanding

aa.aa

11.14

Dividend Per Share

aa.aa

0.85

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

-3.86

-3.95

32.88

-3.38

-3.26

EBITDA Growth

aa.aa

+33.66%

-2.46%

+932.06%

-110.28%

+3.7%

EBITDA Margin %

aa.aa

-25.35%

-1,321.74%

10,997.66%

-1,261.94%

-206.53%

EBIT

aa.aa

-4.05

-4.06

32.81

-3.4

-3.28

* In Millions of PLN (except for per share items)

FAQ

What was Pharmena’s revenue at year end?

At the end of the last reported fiscal year, Pharmena (PHR) recorded total revenue of 1.58 million PLN.

How much revenue did Pharmena report in the most recent quarter?

In its most recent quarterly earnings report, Pharmena posted revenue of 0.39 million PLN.

What was Pharmena’s net income for the year?

For the full year, Pharmena reported net income of -2.77 million PLN.

How much net income did Pharmena post in the last quarter?

In the most recent quarter, Pharmena (PHR) posted net income of -0.89 million PLN.

What was Pharmena’s gross profit for the year?

Gross profit for the year was reported at 1.31 million PLN.

How much gross profit did Pharmena generate last quarter?

Pharmena recorded gross profit of 0.31 million PLN in its latest quarterly report.

What was Pharmena’s annual operating income?

For the full year, Pharmena (PHR) reported operating income of -3.28 million PLN.

What was Pharmena’s operating income last quarter?

Quarterly operating income was -0.95 million PLN.

What was Pharmena’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at -0.95 million PLN.

What was the quarter-over-quarter change in EBITDA for Pharmena?

EBITDA changed by -24.70% million PLN compared to the last quarter.

What is Pharmena’s most recent gross profit margin?

The latest reported gross profit margin for Pharmena (PHR) is 79.54% million PLN.

What is Pharmena’s most recent net income margin?

Net income margin based on recent financials is -227.62% million PLN.

What is Pharmena’s most recent EBIT margin?

Pharmena reported an EBIT margin of -243.22% million PLN based on current figures.

How did Pharmena’s revenue change compared to the previous quarter?

Revenue changed by -3.93% million PLN compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Pharmena?

In the latest quarter, gross profit changed by -77.43% million PLN from the previous quarter.

PSEi Composite

5,943.49

-40.32

-0.67%

Nikkei 225

59,716.18

+575.95

+0.97%

Shanghai

4,079.90

-13.35

-0.33%

US 500

7,164.00

+55.7

+0.78%

US Tech 100

27,301.70

+519.1

+1.94%

DAX

24,128.98

-26.47

-0.11%

Dollar Index

98.36

-0.240

-0.24%

Market Movers

Name	Last	Chg. %	Vol.
Ayala Land	15.800	-3.30%	26.04M
SM Prime	19.980	-0.60%	9.55M
BDO Unibank	115.00	-2.29%	8.71M
Bank of the Philippine Islands	92.10	-3.46%	6.90M
Robinsons Retail	45.900	-1.18%	5.21M
Metropolitan Bank	67.50	+0.60%	2.65M
International Container	710.000	0.00%	980.37K

Name	Last	Chg. %	Vol.
Imperial Resources	1.04	+15.56%	7.00K
Island Information and Tech	0.1310	+10.08%	8.46M
PTFC Redevelop	55.000	+10.00%	3.04K
Max’s Group	2.310	+10.00%	326.00K
Geograce Resources	0.094	+9.30%	3.05M
Victorias Milling Company	2.170	+8.50%	5.00K
F&J Prince	2.600	+8.33%	15.00K

Name	Last	Chg. %	Vol.
Crown Equities	0.076	-8.43%	350.00K
Apollo Global	0.0081	-7.95%	1.58B
Philippine Realty	0.101	-6.48%	350.00K
Vantage Equities	0.9300	-6.06%	60.00K
Primex	1.100	-5.98%	22.00K
Dito CME Holdings	1.0000	-4.76%	104.95M
Century Properties PrfB	100.20	-4.57%	60.00

Trending Stocks

Name	Last	Chg. %	Vol.
Ayala Land	15.800	-3.30%	26.04M
Megaworld	2.060	-2.37%	5.39M
BDO Unibank	115.00	-2.29%	8.71M
Keepers Holdings	1.900	-1.04%	4.11M
Bank of the Philippine Islands	92.10	-3.46%	6.90M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaaaa Aa	1.950	+55.20%	3.026
Aaaaaaaaa	28.400	+51.31%	42.972
Aaaaaaaa	3.560	+48.68%	5.293
Aaaaaaaaa Aaa	2.920	+47.51%	4.307
Aaaaaaaaaa	2.020	+42.54%	2.879
Aa Aa Aaaa Aaaaa	15.800	+42.48%	22.512
Aaaaaaaaaaaaa	1.900	+40.55%	2.670

Name	Last	Upside	Fair Value
Aaaaaaaaa Aa	1.950	+55.20%	3.026
Aaaaaaaaa	28.400	+51.31%	42.972
Aaaaaaaa	3.560	+48.68%	5.293
Aaaaaaaaa Aaa	2.920	+47.51%	4.307
Aaaaaaaaaa	2.020	+42.54%	2.879
Aa Aa Aaaa Aaaaa	15.800	+42.48%	22.512
Aaaaaaaaaaaaa	1.900	+40.55%	2.670

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Pharmena (PHR)

PHR Income Statement

FAQ

What was Pharmena’s revenue at year end?

How much revenue did Pharmena report in the most recent quarter?

What was Pharmena’s net income for the year?

How much net income did Pharmena post in the last quarter?

What was Pharmena’s gross profit for the year?

How much gross profit did Pharmena generate last quarter?

What was Pharmena’s annual operating income?

What was Pharmena’s operating income last quarter?

What was Pharmena’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Pharmena?

What is Pharmena’s most recent gross profit margin?

What is Pharmena’s most recent net income margin?

What is Pharmena’s most recent EBIT margin?

How did Pharmena’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Pharmena?

Trending Stocks